STROUHALOVA, D., D. MACEJOVA, B. MOSNA, Pavel BOBÁĽ, Jan OTEVŘEL, M. LASTOVICKOVA, J. BRTKO and J. BOBALOVA. Down-regulation of vimentin by triorganotin isothiocyanates-nuclear retinoid X receptor agonists: A proteomic approach. Toxicology Letters. CLARE: Elsevier, 2020, vol. 318, No 318, p. 22-29. ISSN 0378-4274. Available from: https://dx.doi.org/10.1016/j.toxlet.2019.10.004.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Down-regulation of vimentin by triorganotin isothiocyanates-nuclear retinoid X receptor agonists: A proteomic approach
Authors STROUHALOVA, D., D. MACEJOVA, B. MOSNA, Pavel BOBÁĽ (703 Slovakia, belonging to the institution), Jan OTEVŘEL (203 Czech Republic, belonging to the institution), M. LASTOVICKOVA, J. BRTKO and J. BOBALOVA.
Edition Toxicology Letters, CLARE, Elsevier, 2020, 0378-4274.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30104 Pharmacology and pharmacy
Country of publisher Ireland
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 4.372
RIV identification code RIV/00216224:14160/20:00118220
Organization unit Faculty of Pharmacy
Doi http://dx.doi.org/10.1016/j.toxlet.2019.10.004
UT WoS 000496792900003
Keywords in English Triorganotin isothiocyanates; Breast cancer; Proteomic; iTRAQ; Vimentin
Tags rivok, ÚChL
Tags International impact, Reviewed
Changed by Changed by: Mgr. Hana Hurtová, učo 244985. Changed: 24/2/2021 08:46.
Abstract
An attempt has been made to delineate the role of natural and synthetic retinoid receptor ligands on vimentin expression in the human triple-negative breast cancer cells. The effects of currently synthesized triorganotin derivatives of the general formula R3SnX (R is butyl or phenyl, X is isothiocyanate), which are considered RXR ligands, were investigated in the human MDA-MB-231 breast cancer cell line. Studies were evaluated in the presence and absence of all-trans retinoic acid (ATRA), a natural RAR ligand. Vimentin represents the major protein associated with epithelial-mesenchymal transition (EMT), an essential process when the primary tumour transforms into a malignant one. mRNA and proteomic data obtained in this study, based on the PDQuest software protein evaluation and further quantification of proteins by iTRAQ analysis, suggest that vimentin was significantly reduced in the combination of RAR ligand and RXR ligand treatment. Both tested triorganotin compounds showed similarly reduced expression of vimentin, but tributyltin isothiocyanate (TBT-ITC) proved to be more effective than triphenyltin isothiocyanate (TPT-ITC). Furthermore, the effect of natural (9cRA) and synthetic RXR ligands, both chloride and isothiocyanate derivatives, on vimentin expression was compared.
PrintDisplayed: 28/7/2024 10:28